Robin Shane Readnour - 17 Aug 2026 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Reporting relationship: Director
Issuer ticker: ANTX
Reported as of: 17 Aug 2026
Net transaction value: -$212,702
SEC form: 4
Accepted by SEC: 19 Aug 2026, 17:58:27 UTC
Prior SEC filing: 23 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Eric Easom, Attorney-in-Fact for Robin Shane Readnour

Key filing fact

Robin Shane Readnour filed Form 4 for AN2 Therapeutics, Inc. (ANTX) on 19 Aug 2026.

Key facts

This page summarizes Robin Shane Readnour's Form 4 filing for AN2 Therapeutics, Inc. (ANTX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Aug 2026, 17:58.

Change

Previous filing in this sequence was filed on 23 Mar 2026.
Current net transaction value: -$212,702.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001914883 Primary reporting owner

Readnour Robin Shane

Relationship: Director
Address: C/O AN2 THERAPEUTICS, INC., 1300 EL CAMINO REAL, SUITE 100, MENLO PARK
Signature: /s/ Eric Easom, Attorney-in-Fact for Robin Shane Readnour
Signature date: 19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANTX transaction

Common Stock

Sale

Transaction value: $100,313
Shares: -16,696
Change %: -2.9%
Price: $6.01
Shares after: 565,592
Date: 17 Aug 2026
Ownership: See footnotes
Footnotes: F1, F3, F4, F5

ANTX transaction

Common Stock

Sale

Transaction value: $112,389
Shares: -18,706
Change %: -2.9%
Price: $6.01
Shares after: 633,867
Date: 17 Aug 2026
Ownership: See footnotes
Footnotes: F2, F3, F4, F6

ANTX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,077
Date: 17 Aug 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by MGC Venture Partners 2018, LP ("MGC 2018 LP") on April 23, 2026.

Footnote F2

The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by MGC Venture Partners QP 2018, LP ("MGC 2018 QP") on April 23, 2026.

Footnote F3

Represents the weighted average sale price for multiple transactions ranging from $6.00 to $6.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range reported herein.

Footnote F4

MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP. MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.

Footnote F5

Shares held directly by MGC 2018 LP.

Footnote F6

Shares held directly by MGC 2018 QP.